Status:
COMPLETED
Evaluation of the Effectiveness of the Selected Method of Treatment of Primary Burning Mouth Syndrome
Lead Sponsor:
Wroclaw Medical University
Conditions:
Burning Mouth Syndrome
Glossodynia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The burning mouth syndrome (BMS) is a chronic pain syndrome of the oral mucosa. Feels like experiencing a burning sensation, pain, stinging, or numbness in the mouth along with a feeling of dryness, p...
Detailed Description
The burning mouth syndrome (BMS) is a chronic pain syndrome of the oral mucosa. Patients have experiencing a burning sensation, pain, stinging, or numbness in the mouth along with a feeling of dryness...
Eligibility Criteria
Inclusion
- History of BMS for at least 6 months
- no clinical changes in the oral cavity that are clinically verifiable and may affect symptoms,
- no previous BMS therapy
- age over 18
Exclusion
- V and VII nerve neuralgia
- patients with uncontrolled diabetes mellitus,
- thyroid disease, anemia,
- Sjogren's disease and
- connective tissue disease (fibromyalgia),
- patients after prior surgical / neurosurgical treatment of the head,
- oncological treatment (radiotherapy),
- pregnant women,
- the occurrence of clinical pathologies in the oral cavity that may cause pain,
- deficiencies of vitamin B12, folic acid
Key Trial Info
Start Date :
January 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 6 2020
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT04884503
Start Date
January 12 2019
End Date
September 6 2020
Last Update
July 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jacek Zborowski
Wroclaw, Lower Silesian Voivodeship, Poland, 52-311